Ehsan Malek, MD
Medical Oncology
Specializing In:
Plasma Cell Disorders Monoclonal Gammopathy of Undetermined Significance (MGUS) Smoldering Myeloma Amyloidosis Bone Marrow Transplantation Stem Cell Transplantation Immunotherapy
Medical Oncology
Specializing In:
Plasma Cell Disorders Monoclonal Gammopathy of Undetermined Significance (MGUS) Smoldering Myeloma Amyloidosis Bone Marrow Transplantation Stem Cell Transplantation Immunotherapy
Related Videos
Two New CAR T-cell Therapy Trials Focus on Relapsed Multiple Myeloma
A pair of open and enrolling clinical trials are offering strong preliminary results for patients with relapsed multiple myeloma, says Ehsan Malek, MD, Director of Multiple Myeloma Translational Research at Roswell Park Comprehensive Cancer Center.
Meet the Team: Dr. Ehsan Malek
As the Director of the Multiple Myeloma Translational Research Program at Roswell Park, Dr. Malek brings with him a passion for finding new and innovative treatments for this disease and other plasma cell disorders